VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | LABMT: impact of treatment prior to allogenic HCT in MDS

Fernando Barroso Duarte, MD, Federal University of Ceara, Clinical Hospital, Fortaleza, Brazil discusses the results of the Latin American Bone Marrow Transplant (LABMT) registry on the impact of treatment prior to allogeneic hematopoietic cell transplantation (HCT) in myelodysplastic syndromes (MDS). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter